Methods of diagnosis and treatment

The FSBI “National Medical Research Radiological Centre” of the Ministry of Health of Russian Federation is one of the largest oncology and radiology clusters in Russia, the leading institution in radiology, a reference center in the field of pathological and morphological research and radiation diagnostics and therapy.

Since 2020, it has also served as the base organization of the CIS member states in the field of oncology.

The Center runs two federal registers: the Cancer registry and the National radiation and epidemiological registry of the Russian Federation.

Possessing a high scientific potential, the Center is engaged in fundamental research and development of new cancer diagnostics and treatment methods and their implementation in clinical practice.

The Center has at its disposal all types of modern linear accelerators, including Gamma and Cyber knives, the first and only Russian proton accelerator “Prometheus”, which enables to irradiate all kinds and sizes of malignant tumors. Center implements such innovative technologies such as HIPEC and PIPAC, X-ray surgical methods of treatment, radionuclide and brachytherapy, robotic-assisted surgery with the da Vinci Surgical System.

The Center has patented and is actively applying a method for preserving the reproductive functions of cancer patients using cryopreservation of genetic material.

A unique for Russia department of reconstructive plastic surgery of radiation injuries has been created.

The Center is one of the leaders in the field of Nuclear Medicine, development of Russian radiopharmaceuticals and their implementation in clinical practice. Nuclear medicine technologies in combined and complex treatment provide significant / additional therapeutic benefits for both oncological and non-oncological diseases.

The Pharmacy manufactures innovative radiopharmaceuticals based on 188Re, 177Lu and 225Ac radionuclides developed at the Center for the treatment of metastatic prostate cancer, primary and metastatic liver cancer, metastatic skeletal lesions and knee joint chronic synovitis.

It is planned to manufacture radiopharmaceuticals for the treatment of neuroendocrine malignant neoplasms, non-Hodgkin’s lymphoma, etc.

GMP – research and production center produces biotechnological drugs: CAR-T cells, stem cells, oncolytic and mRNA vaccines, opening new horizons in oncological and oncohematological diseases treatment.